Cargando…

Systemic immune-inflammation index is associated with diabetic kidney disease in Type 2 diabetes mellitus patients: Evidence from NHANES 2011-2018

OBJECTIVE: Diabetic kidney disease (DKD) is the most common chronic kidney disease (CKD) and has the highest prevalence of end-stage kidney disease (ESKD) globally, owing mostly to the rise in Type 2 diabetes mellitus (T2DM) correlated with obesity. Current research suggested that the immune respons...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Wencong, Song, Yancheng, Sun, Yan, Du, Huasheng, Cai, Yan, You, Qingqing, Fu, Haixia, Shao, Leping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763451/
https://www.ncbi.nlm.nih.gov/pubmed/36561561
http://dx.doi.org/10.3389/fendo.2022.1071465
_version_ 1784853063215874048
author Guo, Wencong
Song, Yancheng
Sun, Yan
Du, Huasheng
Cai, Yan
You, Qingqing
Fu, Haixia
Shao, Leping
author_facet Guo, Wencong
Song, Yancheng
Sun, Yan
Du, Huasheng
Cai, Yan
You, Qingqing
Fu, Haixia
Shao, Leping
author_sort Guo, Wencong
collection PubMed
description OBJECTIVE: Diabetic kidney disease (DKD) is the most common chronic kidney disease (CKD) and has the highest prevalence of end-stage kidney disease (ESKD) globally, owing mostly to the rise in Type 2 diabetes mellitus (T2DM) correlated with obesity. Current research suggested that the immune response and inflammation may play a role in the pathophysiology of T2DM. The systemic immune-inflammation index (SII) is a novel and integrated inflammatory biomarker that has not yet been linked to DKD. We aimed to identify the potential relationship between SII and DKD. METHODS: In the National Health and Nutrition Examination Survey (NHANES) between 2011 and 2018, the current cross-sectional study was conducted among adults with T2DM. SII was calculated as the platelet count × neutrophil count/lymphocyte count. DKD was diagnosed with impaired glomerular filtration rate (< 60 mL/min/1.73 m(2) assessed by using the Chronic Kidney Disease Epidemiology Collaboration algorithm), albuminuria (urine albumin to creatinine ratio ≥ 30 mg/g), or both in T2DM patients. To investigate the independent association between SII and DKD, weighted univariate and multivariable logistic regression analyses and subgroup analyses were performed. RESULTS: The study involved 3937 patients in total, of whom 1510 (38.4%) had DKD for the diagnosis. After adjustment for covariates, multivariable logistic regression revealed that a high SII level was associated with increased likelihood of DKD (OR = 1.42, 95% CI: 1.10-1.83, P = 0.01). Subgroup analyses and interaction tests revealed that age, gender, estimated glomerular filtration rate (eGFR), urine albumin-to-creatinine ratio (ACR), body mass index (BMI), hypertension, hyperlipidemia, anti-inflammation therapy (yes or no), metformin use (yes or no), and insulin use (yes or no) had no significant dependence on this positive relationship (all p for interaction >0.05). CONCLUSIONS: Our results indicate that the higher SII level is associated with DKD in T2DM patients. The SII could be a cost-effective and straightforward approach to detecting DKD. This needs to be verified in further prospective investigations.
format Online
Article
Text
id pubmed-9763451
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-97634512022-12-21 Systemic immune-inflammation index is associated with diabetic kidney disease in Type 2 diabetes mellitus patients: Evidence from NHANES 2011-2018 Guo, Wencong Song, Yancheng Sun, Yan Du, Huasheng Cai, Yan You, Qingqing Fu, Haixia Shao, Leping Front Endocrinol (Lausanne) Endocrinology OBJECTIVE: Diabetic kidney disease (DKD) is the most common chronic kidney disease (CKD) and has the highest prevalence of end-stage kidney disease (ESKD) globally, owing mostly to the rise in Type 2 diabetes mellitus (T2DM) correlated with obesity. Current research suggested that the immune response and inflammation may play a role in the pathophysiology of T2DM. The systemic immune-inflammation index (SII) is a novel and integrated inflammatory biomarker that has not yet been linked to DKD. We aimed to identify the potential relationship between SII and DKD. METHODS: In the National Health and Nutrition Examination Survey (NHANES) between 2011 and 2018, the current cross-sectional study was conducted among adults with T2DM. SII was calculated as the platelet count × neutrophil count/lymphocyte count. DKD was diagnosed with impaired glomerular filtration rate (< 60 mL/min/1.73 m(2) assessed by using the Chronic Kidney Disease Epidemiology Collaboration algorithm), albuminuria (urine albumin to creatinine ratio ≥ 30 mg/g), or both in T2DM patients. To investigate the independent association between SII and DKD, weighted univariate and multivariable logistic regression analyses and subgroup analyses were performed. RESULTS: The study involved 3937 patients in total, of whom 1510 (38.4%) had DKD for the diagnosis. After adjustment for covariates, multivariable logistic regression revealed that a high SII level was associated with increased likelihood of DKD (OR = 1.42, 95% CI: 1.10-1.83, P = 0.01). Subgroup analyses and interaction tests revealed that age, gender, estimated glomerular filtration rate (eGFR), urine albumin-to-creatinine ratio (ACR), body mass index (BMI), hypertension, hyperlipidemia, anti-inflammation therapy (yes or no), metformin use (yes or no), and insulin use (yes or no) had no significant dependence on this positive relationship (all p for interaction >0.05). CONCLUSIONS: Our results indicate that the higher SII level is associated with DKD in T2DM patients. The SII could be a cost-effective and straightforward approach to detecting DKD. This needs to be verified in further prospective investigations. Frontiers Media S.A. 2022-12-06 /pmc/articles/PMC9763451/ /pubmed/36561561 http://dx.doi.org/10.3389/fendo.2022.1071465 Text en Copyright © 2022 Guo, Song, Sun, Du, Cai, You, Fu and Shao https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Guo, Wencong
Song, Yancheng
Sun, Yan
Du, Huasheng
Cai, Yan
You, Qingqing
Fu, Haixia
Shao, Leping
Systemic immune-inflammation index is associated with diabetic kidney disease in Type 2 diabetes mellitus patients: Evidence from NHANES 2011-2018
title Systemic immune-inflammation index is associated with diabetic kidney disease in Type 2 diabetes mellitus patients: Evidence from NHANES 2011-2018
title_full Systemic immune-inflammation index is associated with diabetic kidney disease in Type 2 diabetes mellitus patients: Evidence from NHANES 2011-2018
title_fullStr Systemic immune-inflammation index is associated with diabetic kidney disease in Type 2 diabetes mellitus patients: Evidence from NHANES 2011-2018
title_full_unstemmed Systemic immune-inflammation index is associated with diabetic kidney disease in Type 2 diabetes mellitus patients: Evidence from NHANES 2011-2018
title_short Systemic immune-inflammation index is associated with diabetic kidney disease in Type 2 diabetes mellitus patients: Evidence from NHANES 2011-2018
title_sort systemic immune-inflammation index is associated with diabetic kidney disease in type 2 diabetes mellitus patients: evidence from nhanes 2011-2018
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763451/
https://www.ncbi.nlm.nih.gov/pubmed/36561561
http://dx.doi.org/10.3389/fendo.2022.1071465
work_keys_str_mv AT guowencong systemicimmuneinflammationindexisassociatedwithdiabetickidneydiseaseintype2diabetesmellituspatientsevidencefromnhanes20112018
AT songyancheng systemicimmuneinflammationindexisassociatedwithdiabetickidneydiseaseintype2diabetesmellituspatientsevidencefromnhanes20112018
AT sunyan systemicimmuneinflammationindexisassociatedwithdiabetickidneydiseaseintype2diabetesmellituspatientsevidencefromnhanes20112018
AT duhuasheng systemicimmuneinflammationindexisassociatedwithdiabetickidneydiseaseintype2diabetesmellituspatientsevidencefromnhanes20112018
AT caiyan systemicimmuneinflammationindexisassociatedwithdiabetickidneydiseaseintype2diabetesmellituspatientsevidencefromnhanes20112018
AT youqingqing systemicimmuneinflammationindexisassociatedwithdiabetickidneydiseaseintype2diabetesmellituspatientsevidencefromnhanes20112018
AT fuhaixia systemicimmuneinflammationindexisassociatedwithdiabetickidneydiseaseintype2diabetesmellituspatientsevidencefromnhanes20112018
AT shaoleping systemicimmuneinflammationindexisassociatedwithdiabetickidneydiseaseintype2diabetesmellituspatientsevidencefromnhanes20112018